Balyasny Asset Management LLC Guardant Health, Inc. Call Options Transaction History

Balyasny Asset Management LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$22.3 - $36.29 $2.19 Million - $3.56 Million	98,100 New	98,100 $2.25 Million
Q3 2022 Nov 14, 2022	BUY	$43.66 - $61.0 $3.73 Million - $5.21 Million	85,400 Added 341.6%	110,400 $5.94 Million
Q2 2022 Aug 15, 2022	SELL	$28.82 - $77.35 $9.48 Million - $25.4 Million	-329,000 Reduced 92.94%	25,000 $1.01 Million
Q1 2022 May 16, 2022	BUY	$48.25 - $100.49 $16.4 Million - $34.2 Million	340,000 Added 2428.57%	354,000 $23.4 Million
Q4 2021 Feb 14, 2022	BUY	$88.71 - $120.43 $1.24 Million - $1.69 Million	14,000 New	14,000 $1.4 Million

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.23B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.